Clinical, radiological, and functional assessment in psoriatic arthritis: is it different from other inflammatory joint diseases?

被引：38

作者：

Gladman, D. D. ^{[1
]}

机构：

[1] Toronto Western Hosp, Ctr Prognosis Studies Rheumat Dis, Toronto, ON M5T 2S8, Canada

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷

关键词：

D O I：

10.1136/ard.2006.058453

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：22 / 24

页数：3

共 27 条

[1] Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis - Results from the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT) [J].

Antoni, CE ;

Kavanagh, A ;

Kirkham, B ;

Tutuncu, Z ;

Burmester, GR ;

Schneider, U ;

Furst, DE ;

Molitor, J ;

Keystone, E ;

Gladman, D ;

Manger, B ;

Wassenberg, S ;

Weier, R ;

Wallace, DJ ;

Weisman, MH ;

Kalden, JR ;

Smolen, J .

ARTHRITIS AND RHEUMATISM, 2005, 52 (04) :1227-1236

[2]

BLACKMORE MG, 1995, J RHEUMATOL, V22, P886

[3] Hyperuricemia in psoriatic arthritis - Prevalence and associated features [J].

Bruce, IN ;

Schentag, CT ;

Gladman, DD .

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2000, 6 (01) :6-9

[4]

BUSKILA D, 1992, J RHEUMATOL, V19, P1115

[5]

Danning CL, 2000, ARTHRITIS RHEUM-US, V43, P1244, DOI 10.1002/1529-0131(200006)43:6<1244::AID-ANR7>3.0.CO

[6]

2-2

[7]

DUFFY CM, 1992, J RHEUMATOL, V19, P1727

[8]

Fearon U, 2003, J RHEUMATOL, V30, P260

[9]

GLADMAN DD, 1993, CLIN INVEST MED, V16, P1

[10]

GLADMAN DD, 1986, J RHEUMATOL, V13, P586

← 1 2 3 →